Navigation Links
Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as Part of Their Pre-Combine Training Regime

NCAA Football Players Currently in Training and Preparing for the NFL Combine Use SURGEX(TM) as part of their Training Program at TEST Sports


BASKING RIDGE, N.J., Jan. 15 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG), announced today that SURGEX(TM) is currently being administered as part of the nutritional program provided to elite Division I & II Collegiate Football Athletes training for the NFL Combine at TEST Sports Clubs(TM) ( in Martinsville, New Jersey. Athletes preparing to enter the NFL Draft in April representing teams from the SEC, ACC, Big Ten, Big XII and Big East are using the SURGEX(TM) product as part of the Football Academy: NFL Combine Training at TEST Sports Clubs.

SURGEX(TM) is one of five co-sponsors of the NFL Combine Training Program currently underway at TEST Sports Clubs. Other co-sponsors include Under Armor(R), EAS(R), Power Plate(R) and Amino Vital(R). TEST Sports Clubs Partner and COO Kevin Dunn is proud to offer SURGEX(TM) to his athletes for their post training nutritional needs, "TEST Sports Clubs are committed to providing only premier, science based products and services to our athletes. SURGEX(TM) represents the elite formula these athletes require to assist in proper recovery following intense training sessions and workouts."

Millennium's recently launched SURGEX(TM) product line is used by world class collegiate and professional athletes in some of the most intense athletic training programs in world. The SURGEX(TM) formula is certified by the Banned Substance Control Group (BSCG) to contain no banned substances. "As an alternative to stimulants and excess protein based products that dominate the sports market, SURGEX(TM) represents true alternative formula that addresses the multiple nutritional needs of the athlete. With several double blind, placebo controlled clinical trials in Division 1 athletes behind it, SURGEX(TM) is the only nutritional formula shown to influence recovery, strength, body composition and endurance parameters." states Millennium's Vice President of Research and Product Development Carl Germano, RD, CNS, CDN. "The success of SURGEX(TM) in sports is based upon the products ability to help the athlete recover from the damaging effects of strenuous activity. If you can recover better, you can perform better. We view and treat the athlete in the sports marketplace the same as we successfully do with critically ill patients in the medical marketplace through optimized recovery and rehabilitation."

Headed by a distinguished staff of former Super Bowl Champions, NFL and Collegiate standout performers and other strength and conditioning and training specialists TEST Sports Clubs are one of the preeminent training facilities in the country. The TEST Football Academy specializes in preparing top collegiate football players for the annual NFL Combine.


SURGEX(TM) ( was created from Millennium's extensive experience providing advanced nutritional formulas to some of the most prestigious medical institutions throughout the United States The proprietary SURGEX(TM) formula intends to meet the growing demand of elite level professional and amateur athletes and their coaches looking for nutritional support in a marketplace dominated by products with no clinical proof of benefit, unsubstantiated claims, excess protein, stimulants, and banned substances.

In double blind placebo controlled trials at the Rutgers University Human Performance Lab SURGEX(TM) significantly outperformed leading competitive products by assisting in reducing the damaging effects of exercise by improving peak power outputs, lowering oxidative stress/inflammatory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as the lessening of free radical production (oxidative stress). The formula meets NCAA guidelines for use by collegiate athletes and is certified by The Banned Substances Control Group (BSCG) to contain no banned substances.

About Millennium:

Millennium's three proprietary, marketed products, which form the Company's Resurgex(R) Continuum of Care, include Resurgex Select(R), Resurgex(R), and Resurgex Plus(R). Resurgex Select(R) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support post-treatment. Millennium is also recently developed a SURGEX(TM) sports nutrition formula, clinically proven to address the nutritional concerns of both professional and amateur elite athletes. These athletes often experience similar symptoms post-workout to those battling immuno-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function.

Statements in this news release regarding future financial and operating results, future growth in R&D programs, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward- looking statements including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of the Company's intellectual property, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including Forms 10-KSB, 10-QSB, 8-K, and other forms filed with the Securities and Exchange Commission ("SEC"). These statements have not been evaluated by the Food and Drug Administration. Resurgex(R), Resurgex Plus(R), Resurgex Select(R) and SURGEX(TM) are not intended to diagnose, treat, cure, or prevent and disease.

SOURCE Millennium Biotechnologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Workforce Alliance Concludes Three-Year Biotech Training Program
2. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
3. Beaumont Technology Usability Center To Offer Training For Medical Technology Companies
4. CCMR gets $2.9M for training grad students in nanoscale science
5. CCMR gets $2.9M for training grad students in nanoscale science
6. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
7. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
8. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
9. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
10. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
11. Statement on the Release of the European Food Safety Assessment on the Safety of Food Derived From Clones and Their Offspring in the Food Supply
Post Your Comments:
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... Inc., a worldwide provider of clinical research services headquartered in ... has set a new quarterly earnings record in Q3 of 2015.  ... Q3 of 2014 to Q3 of 2015.   ... the establishment of an Asia-Pacific office to ... and Mexico , with the establishment ...
(Date:11/24/2015)... York , November 24, 2015 ... a recent market research report released by Transparency Market ... to expand at a CAGR of 17.5% during the ... Prenatal Testing Market - Global Industry Analysis, Size, Volume, ... the global non-invasive prenatal testing market to reach a ...
Breaking Biology Technology:
(Date:11/17/2015)... Nov. 17, 2015 Pressure BioSciences, Inc. (OTCQB: ... development and sale of broadly enabling, pressure cycling technology ... industry, today announced it has received gross proceeds of ... Private Placement (the "Offering"), increasing the total amount raised ... more additional closings are expected in the near future. ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , an ... of clinical research, is pleased to announce that it will ... Trials (PCT) event, to be held November 17-19 in ... to view live demonstrations of iMedNet , ... how iMedNet has been able to deliver time ...
(Date:11/4/2015)... November 4, 2015 --> ... report published by Transparency Market Research "Home Security Solutions Market ... Forecast 2015 - 2022", the global home security solutions market is ... by 2022. The market is estimated to expand at ... 2015 to 2022. Rising security needs among customers at ...
Breaking Biology News(10 mins):